Development of a Practice Protocol for the Use of Long Acting Injectable Antipsychotic Medications in the Emergency Department Public Deposited

Downloadable Content

Download PDF
Last Modified
  • December 3, 2020
  • Smith, Anusha
    • Affiliation: School of Nursing
  • Background: Long acting injectable antipsychotic (LAI) medications were developed to improve adherence in patients with psychotic disorders. Studies have shown patient on these medications have reduced inpatient admissions and Emergency Department (ED) visits. Aim: To develop a practice protocol which identifies patients who could benefit from a long acting injectable while in the ED setting. The goal of the project was to educate the providers about how to use the long acting injectable antipsychotic medications in their treatment plans and provide tips on how to have a discussion with the patient. Methods: A quality improvement project which educates mental health providers in the ED about the practice protocol and how to implement it through a 1.5-hour education session. Data from 20 charts were collected from chart reviews of the electronic record. At the completion of the data collection, a group interview was conducted to gather feedback from the providers about the protocol. Results: Of the 20 patients who received the protocol, eight of those patients received the LAI while in the ED. During the interview, Providers were discussing the option of the LAI more consistently. While they felt their knowledge about LAIs did not increase, they did feel the protocol prompted them to have the discussion. Conclusion: The findings suggest the practice protocol can increase awareness, provide guidance regarding treatment and increase utilization of LAIs in the ED setting.
Date of publication
Resource type
  • Mando, Jennifer
  • Hubbard, Grace
  • Giscombe, Cheryl
Degree granting institution
  • University of North Carolina at Chapel Hill
Graduation year
  • 2018

This work has no parents.